<!DOCTYPE html><html xml:lang="en" lang="en" xmlns="http://www.w3c.org/1999/xhtml">
  <head>
    <meta http-equiv="content-type" content="text/html; charset=utf-8" />
    <title>SSSNFL_H</title>
    <meta name="title" content="NHANES 2013-2014: Serum Neurofilament Light Chain - Serum Data Documentation, Codebook, and Frequencies" />
    <link rel="stylesheet" href="https://wwwn.cdc.gov/nchs/nhanes/css/documentation.css" />
  </head>
  <body class="nhanes-doc">
    <div id="toc">
      <h3>Table of Contents</h3>
      <div id="toc-scroll">
        <ul>
          <li>
            <a href="#Component_Description">Component Description</a>
          </li>
          <li>
            <a href="#Eligible_Sample">Eligible Sample</a>
          </li>
          <li>
            <a href="#Description_of_Laboratory_Methodology">Description of Laboratory Methodology</a>
          </li>
          <li>
            <a href="#Laboratory_Quality_Assurance_and_Monitoring">Laboratory Quality Assurance and Monitoring</a>
          </li>
          <li>
            <a href="#Data_Processing_and_Editing">Data Processing and Editing</a>
          </li>
          <li>
            <a href="#Analytic_Notes">Analytic Notes</a>
          </li>
          <li>
            <a href="#References">References</a>
          </li>
          <li>
            <a href="#Codebook">Codebook</a>
            <ul id="CodebookLinks">
              <li>
                <a href="#SEQN">SEQN - Respondent sequence number</a>
              </li>
              <li>
                <a href="#WTSSNH2Y">WTSSNH2Y - SSSNFL_H 2 year weights</a>
              </li>
              <li>
                <a href="#SSSNFL">SSSNFL - Serum neurofilament light chain (pg/ml)</a>
              </li>
              <li>
                <a href="#SSNFLH">SSNFLH - Serum neurofilament above detect limit</a>
              </li>
              <li>
                <a href="#SSNFLL">SSNFLL - Serum neurofilament below detect limit</a>
              </li>
            </ul>
          </li>
        </ul>
      </div>
    </div>
    <div id="wrapper">
      <div id="PageHeader">
        <h1>National Health and Nutrition Examination Survey</h1>
        <h2>2013-2014 Data Documentation, Codebook, and Frequencies</h2>
        <h3>Serum Neurofilament Light Chain - Serum (SSSNFL_H)</h3>
        <h4> Data File: SSSNFL_H.xpt</h4>
        <h5 class="left">First Published: June 2022</h5>
        <h5 class="right">Last Revised: NA</h5>
      </div>
      <div id="Sections">
        <h2 id="Component_Description">Component Description</h2><p>Neurofilaments are neuron-specific type IV intermediate filament heteropolymers composed of light, medium, and heavy chains (Petzold, 2005). Neurofilaments are the dominant proteins of the neural cytoskeleton and are released into the extracellular space following neuro-axonal damage, and have thus been proposed as putative biomarkers of neuro-axonal injury in multiple neurological diseases (Petzold, 2005; L&eacute;pinoux-Chambaud and Eyer, 2013; Bacioglu et al., 2016). Neurofilament light chain (NfL) especially, has been shown to be a promising biomarker because of its high solubility, and increased NfL levels have been found in the blood and CSF in several neurological disorders with underlying neuro-axonal degeneration, including multiple sclerosis (MS), Alzheimer&rsquo;s disease, Parkinson&rsquo;s disease, Huntington&rsquo;s disease, motor neuron disease, stroke, inherited peripheral neuropathies, and traumatic brain injury (Gunnarsson et al., 2011; Disanto et al., 2016; Weydt et al., 2016; Byrne et al., 2017; De Marchis et al., 2018; Olsson et al., 2019). Elevated concentrations of NfL have also been associated with disease severity in these patient populations, including in MS and other neurologic conditions (Disanto et al., 2017; Preische et al., 2019). Importantly, serum neurofilament light chain (sNfL) has been shown to increase with age in healthy control cohorts; however, age-specific reference ranges have not been well-defined (Disanto et al., 2017). Taken together, higher sNfL values are observed in those with many neurological disorders; however, sNfL levels among those without neurological disorders tend to increase with age.This data will characterize sNfL levels across the age distribution in a representative sample of non-institutionalized US adults.</p><h2 id="Eligible_Sample">Eligible Sample</h2><p>Participants aged 20-75 years in a half-sample from NHANES 2013-2014, who consented to storing their samples for future research and had stored surplus or pristine serum samples, were eligible.</p><h2 id="Description_of_Laboratory_Methodology">Description of Laboratory Methodology</h2><p>Siemens
Healthineers has developed a highly sensitive NfL immunoassay that utilizes
acridinium ester (AE) chemiluminescence and paramagnetic particles and may be run on an existing, high-throughput,
automated platform (Attelica).
Initially, the sample is incubated with acridinium-ester (AE) labeled
antibodies, which bind to the NfL antigen. Following this step, paramagnetic
particles (PMP) coated with capture antibody are added to the sample, forming
complexes of antigen bound to AE-labeled antibodies and PMP. Unbound AE-labeled
antibodies are then separated and removed, following which acid and base are
added to initiate chemiluminescence and light emission is measured. All steps
are performed on the fully automated Attelica
immunoassay system.</p>
<p>Compared to other chemiluminescent
technologies, AE features a number of advantages, including: 1) <strong style="mso-bidi-font-weight:normal;">High quantum yields:</strong> high
signal-to-noise ratio for improved sensitivity and low-end precision; 2) <strong style="mso-bidi-font-weight:normal;">Rapid kinetics</strong> with light emission
complete in 1-5 seconds: high throughput; 3) <strong style="mso-bidi-font-weight:
normal;">Hydrophilicity:</strong> improved efficacy of wash step for low non-specific
binding; 4) <strong style="mso-bidi-font-weight:normal;">Hydrolytic stability:</strong>
long reagent shelf life and extended onboard stability; and 5) <strong style="mso-bidi-font-weight:normal;">Small size:</strong> direct labeling with AE for
use in a broad range of assays.</p><h2 id="Laboratory_Quality_Assurance_and_Monitoring">Laboratory Quality Assurance and Monitoring</h2><p>The analytical
measurements were conducted following strict quality control/quality assurance procedures.
In addition to study samples, low, medium, and high concentration quality
control (QC) samples were run each 8-hour shift as well as additional replicate
samples to ensure accuracy and reliability of the derived data. We calculated
the coefficient of variation (CV) and other relevant statistics to describe the
QC samples across the spectrum of sNfL measures. In addition, as a part of a
related study, sNfL measurement will be performed in spiked control samples
and in a subset of participants (100 HC and 100 MS participants) with
calculation of intra- and inter-assay coefficient of variation. These
participants will be selected in part to have sNfL values that span the entire
range of values observed in the overall cohort.</p><h2 id="Data_Processing_and_Editing">Data Processing and Editing</h2><p>Data were received after all analyses were complete. The
data were not edited.&nbsp;Data Access: All data are publicly available.</p><h2 id="Analytic_Notes">Analytic Notes</h2><p><strong>Subsample Weights</strong> </p>
<p>Subsample
weights are required to analyze these data properly. Specific sample weights (WTSSNH2Y)
for this subsample are included in this data file and should be used when
analyzing these data. Please refer to the NHANES&nbsp;<a href="https://wwwn.cdc.gov/nchs/nhanes/analyticguidelines.aspx" target="_blank">Analytic Guidelines</a>&nbsp;and the on-line&nbsp;<a href="https://wwwn.cdc.gov/nchs/nhanes/tutorials/default.aspx" target="_blank">NHANES&nbsp;</a><a href="https://wwwn.cdc.gov/nchs/nhanes/tutorials/default.aspx" target="_blank">Tutorial</a>&nbsp;for further details on the use of sample
weights and other analytic issues.</p>
<p><strong>Detection Limits </strong></p>
<p>The
lower limit of quantification (LLOQ) of the assay is 3.9 pg/mL, which was
determined by replicate testing (n=44) of low concentration NfL samples. The lower
limit of quantification (LLOQ) was defined as the concentration at which the
coefficient of variation (CV) was less than or equal to 20%.</p>
<p>The detection limits were constant for all of the
analytes in the data set. Two variables are provided for each analyte. The
variable name ending in &ldquo;L&rdquo; (ex., SSNFLL) indicates whether the result was below the LLOQ: the
value &ldquo;0&rdquo; means that the result was at or above the LLOQ, &ldquo;1&rdquo; indicates that
the result was below the LLOQ. A similar variable is ending in &ldquo;H&rdquo; indicates
the result was above the upper limit of quantification (ULOQ) (ex., SSNFLH).<br style="mso-special-character: line-break;" />
</p>
<p>For analytes with analytic results below the LLOQ (ex., SSNFLL=1), an imputed fill value was placed in the analyte
results field equal to the LLOQ divided by the &radic;2. For analytes with analytic results above the ULOQ (ex.,
SSNFLH=1), an imputed fill value was placed in the analyte results field equal
to the ULOQ multiplied by the &radic;2. </p>
<p>The lower limit of quantification (LLOQ, in pg/mL) and
upper limit of quantification (ULOQ, in pg/mL) for SSSNFL are:</p>
<table>
    <tbody>
        <tr>
            <td>&nbsp;<strong>Variable Name</strong></td>
            <td>&nbsp;<strong>SAS             Label</strong></td>
            <td><strong>LLOQ&nbsp;</strong></td>
            <td><strong>ULOQ&nbsp;</strong></td>
        </tr>
        <tr>
            <td>&nbsp;SSSNFL</td>
            <td>&nbsp;Serum            neurofilament light chain (pg/mL)</td>
            <td>&nbsp;3.9 pg/mL </td>
            <td>&nbsp;500 pg/mL</td>
        </tr>
    </tbody>
</table>
<br />
<p><strong>Interferences:</strong></p>
<p>Blanks in an analyte results field represent missing values in cases where sNfL assays did not succeed in obtaining a valid numeric result (e.g., sample quantity was not sufficient).</p></div>
      <div id="References">
        <h2>References</h2>
        <ul>
          <li>Bacioglu M, Maia LF, Preische O, Schelle
J, Apel A, Kaeser SA, et al. Neurofilament Light Chain in Blood and CSF as
Marker of Disease Progression in Mouse Models and in Neurodegenerative
Diseases. Neuron 2016; 91: 494&ndash;6.</li>
          <li>Byrne LM, Rodrigues FB, Blennow K, Durr A, Leavitt BR, Roos RAC, et al.
Neurofilament light protein in blood as a potential biomarker of
neurodegeneration in Huntington&rsquo;s disease: a retrospective cohort analysis. Lancet
Neurol 2017; 16: 601&ndash;9.</li>
          <li>De Marchis GM, Katan M, Barro C, Fladt J, Traenka C, Seiffge DJ, et al. Serum neurofilament light chain in patients with acute cerebrovascular events. Eur J Neurol 2018; 25: 562&ndash;8.</li>
          <li>Disanto G, Adiutori R, Dobson R, Martinelli V, Dalla Costa G, Runia T, et al. Serum neurofilament light chain levels are increased in patients with a clinically isolated syndrome. J Neurol Neurosurg Psychiatry 2016; 87: 126&ndash;9.</li>
          <li>Disanto G, Barro C, Benkert P, Naegelin Y, Sch&auml;delin S, Giardiello A, et al. Serum Neurofilament light: A biomarker of neuronal damage in multiple sclerosis. Ann Neurol 2017; 81: 857&ndash;70.</li>
          <li>Gunnarsson M, Malmestr&ouml;m C, Axelsson M, Sundstr&ouml;m P, Dahle C, Vrethem M, et al. Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab. Ann Neurol 2011; 69: 83&ndash;9.</li>
          <li>L&eacute;pinoux-Chambaud C, Eyer J. Review on intermediate filaments of the nervous system and their pathological alterations. Histochem Cell Biol 2013; 140: 13&ndash;22.</li>
          <li>Olsson B, Portelius E, Cullen NC, Sandelius &Aring;, Zetterberg H, Andreasson U, et al. Association of Cerebrospinal Fluid Neurofilament Light Protein Levels With Cognition in Patients With Dementia, Motor Neuron Disease, and Movement Disorders. JAMA Neurol 2019; 76: 318&ndash;25.</li>
          <li>Petzold A. Neurofilament phosphoforms: surrogate markers for axonal injury, degeneration and loss. J Neurol Sci 2005; 233: 183&ndash;98.</li>
          <li>Preische O, Schultz SA, Apel A, Kuhle J, Kaeser SA, Barro C, et al. Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer&rsquo;s disease. Nat Med 2019; 25: 277&ndash;83.</li>
          <li>Weydt P, Oeckl P, Huss A, M&uuml;ller K, Volk AE, Kuhle J, et al. Neurofilament levels as biomarkers in asymptomatic and symptomatic familial amyotrophic lateral sclerosis. Ann Neurol 2016; 79: 152&ndash;8.</li>
        </ul>
      </div>
      <div id="Codebook">
        <h2>Codebook and Frequencies</h2>
        <div class="pagebreak">
          <h3 class="vartitle" id="SEQN">SEQN - Respondent sequence number</h3>
          <dl>
            <dt>Variable Name: </dt>
            <dd class="info">SEQN</dd>
            <dt>SAS Label: </dt>
            <dd>Respondent sequence number</dd>
            <dt>English Text: </dt>
            <dd class="info">Respondent sequence number.</dd>
            <dt>Target: </dt>
            <dd> Both males and females 20 YEARS -
			75 YEARS</dd>
          </dl>
        </div>
        <div class="pagebreak">
          <h3 class="vartitle" id="WTSSNH2Y">WTSSNH2Y - SSSNFL_H 2 year weights</h3>
          <dl>
            <dt>Variable Name: </dt>
            <dd class="info">WTSSNH2Y</dd>
            <dt>SAS Label: </dt>
            <dd>SSSNFL_H 2 year weights</dd>
            <dt>English Text: </dt>
            <dd class="info">Surplus specimen SSSNFL_H 2 year weights</dd>
            <dt>Target: </dt>
            <dd> Both males and females 20 YEARS -
			75 YEARS</dd>
          </dl>
          <table class="values">
            <thead>
              <tr>
                <th scope="column" class="values">Code or Value</th>
                <th scope="column" class="values">Value Description</th>
                <th scope="column" class="values">Count</th>
                <th scope="column" class="values">Cumulative</th>
                <th scope="column" class="values">Skip to Item</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td scope="row" class="values">14793.649452 to 384147.9949</td>
                <td class="values">Range of Values</td>
                <td class="values" align="right">2071</td>
                <td class="values" align="right">2071</td>
                <td class="values">
                </td>
              </tr>
              <tr>
                <td scope="row" class="values">0</td>
                <td class="values">No lab specimen</td>
                <td class="values" align="right">14</td>
                <td class="values" align="right">2085</td>
                <td class="values">
                </td>
              </tr>
              <tr>
                <td scope="row" class="values">.</td>
                <td class="values">Missing</td>
                <td class="values" align="right">0</td>
                <td class="values" align="right">2085</td>
                <td class="values">
                </td>
              </tr>
            </tbody>
          </table>
        </div>
        <div class="pagebreak">
          <h3 class="vartitle" id="SSSNFL">SSSNFL - Serum neurofilament light chain (pg/ml)</h3>
          <dl>
            <dt>Variable Name: </dt>
            <dd class="info">SSSNFL</dd>
            <dt>SAS Label: </dt>
            <dd>Serum neurofilament light chain (pg/ml)</dd>
            <dt>English Text: </dt>
            <dd class="info">Serum neurofilament light chain (pg/ml)</dd>
            <dt>Target: </dt>
            <dd> Both males and females 20 YEARS -
			75 YEARS</dd>
          </dl>
          <table class="values">
            <thead>
              <tr>
                <th scope="column" class="values">Code or Value</th>
                <th scope="column" class="values">Value Description</th>
                <th scope="column" class="values">Count</th>
                <th scope="column" class="values">Cumulative</th>
                <th scope="column" class="values">Skip to Item</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td scope="row" class="values">2.8 to 497.6</td>
                <td class="values">Range of Values</td>
                <td class="values" align="right">2071</td>
                <td class="values" align="right">2071</td>
                <td class="values">
                </td>
              </tr>
              <tr>
                <td scope="row" class="values">.</td>
                <td class="values">Missing</td>
                <td class="values" align="right">14</td>
                <td class="values" align="right">2085</td>
                <td class="values">
                </td>
              </tr>
            </tbody>
          </table>
        </div>
        <div class="pagebreak">
          <h3 class="vartitle" id="SSNFLH">SSNFLH - Serum neurofilament above detect limit</h3>
          <dl>
            <dt>Variable Name: </dt>
            <dd class="info">SSNFLH</dd>
            <dt>SAS Label: </dt>
            <dd>Serum neurofilament above detect limit</dd>
            <dt>English Text: </dt>
            <dd class="info">Serum neurofilament above detect limit</dd>
            <dt>Target: </dt>
            <dd> Both males and females 20 YEARS -
			75 YEARS</dd>
          </dl>
          <table class="values">
            <thead>
              <tr>
                <th scope="column" class="values">Code or Value</th>
                <th scope="column" class="values">Value Description</th>
                <th scope="column" class="values">Count</th>
                <th scope="column" class="values">Cumulative</th>
                <th scope="column" class="values">Skip to Item</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td scope="row" class="values">0</td>
                <td class="values">At or below the limit of detection</td>
                <td class="values" align="right">2071</td>
                <td class="values" align="right">2071</td>
                <td class="values">
                </td>
              </tr>
              <tr>
                <td scope="row" class="values">1</td>
                <td class="values">Above upper detection limit</td>
                <td class="values" align="right">0</td>
                <td class="values" align="right">2071</td>
                <td class="values">
                </td>
              </tr>
              <tr>
                <td scope="row" class="values">.</td>
                <td class="values">Missing</td>
                <td class="values" align="right">14</td>
                <td class="values" align="right">2085</td>
                <td class="values">
                </td>
              </tr>
            </tbody>
          </table>
        </div>
        <div class="pagebreak">
          <h3 class="vartitle" id="SSNFLL">SSNFLL - Serum neurofilament below detect limit</h3>
          <dl>
            <dt>Variable Name: </dt>
            <dd class="info">SSNFLL</dd>
            <dt>SAS Label: </dt>
            <dd>Serum neurofilament below detect limit</dd>
            <dt>English Text: </dt>
            <dd class="info">Serum neurofilament below detect limit</dd>
            <dt>Target: </dt>
            <dd> Both males and females 20 YEARS -
			75 YEARS</dd>
          </dl>
          <table class="values">
            <thead>
              <tr>
                <th scope="column" class="values">Code or Value</th>
                <th scope="column" class="values">Value Description</th>
                <th scope="column" class="values">Count</th>
                <th scope="column" class="values">Cumulative</th>
                <th scope="column" class="values">Skip to Item</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td scope="row" class="values">0</td>
                <td class="values">At or above the detection limit</td>
                <td class="values" align="right">2035</td>
                <td class="values" align="right">2035</td>
                <td class="values">
                </td>
              </tr>
              <tr>
                <td scope="row" class="values">1</td>
                <td class="values">Below lower detection limit</td>
                <td class="values" align="right">36</td>
                <td class="values" align="right">2071</td>
                <td class="values">
                </td>
              </tr>
              <tr>
                <td scope="row" class="values">.</td>
                <td class="values">Missing</td>
                <td class="values" align="right">14</td>
                <td class="values" align="right">2085</td>
                <td class="values">
                </td>
              </tr>
            </tbody>
          </table>
        </div>
      </div>
    </div>
  </body>
</html>